{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:10:16Z","timestamp":1758877816054,"version":"3.44.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100016168","name":"King Hussein Cancer Center","doi-asserted-by":"publisher","award":["19 KHCC 14","19 KHCC 14","19 KHCC 14","19 KHCC 14","19 KHCC 14","19 KHCC 14"],"award-info":[{"award-number":["19 KHCC 14","19 KHCC 14","19 KHCC 14","19 KHCC 14","19 KHCC 14","19 KHCC 14"]}],"id":[{"id":"10.13039\/100016168","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-025-11469-2","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:30:46Z","timestamp":1758875446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A pilot study evaluating mid-point vancomycin concentrations to estimate pharmacokinetics and area under the curve: a prospective study"],"prefix":"10.1186","volume":"25","author":[{"given":"Aseel","family":"AbuSara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deema","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wedad","family":"Awad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Skyler","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lama","family":"Nazer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"1","key":"11469_CR1","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2146\/ajhp080434","volume":"66","author":"M Rybak","year":"2009","unstructured":"Rybak M, Lomaestro B, Rotschafer JC, Moellering R Jr, Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009;66(1):82\u201398.","journal-title":"Am J Health Syst Pharm"},{"issue":"8","key":"11469_CR2","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/cid\/cir078","volume":"52","author":"N Patel","year":"2011","unstructured":"Patel N, Pai MP, Rodvold KA, Lomaestro B, Drusano GL, Lodise TP. Vancomycin: we can\u2019t get there from here. Clin Infect Dis. 2011;52(8):969\u201374.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"11469_CR3","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.clinthera.2013.05.008","volume":"35","author":"KM Gawronski","year":"2013","unstructured":"Gawronski KM, Goff DA, Brown J, Khadem TM, Bauer KA. A stewardship program\u2019s retrospective evaluation of Vancomycin AUC24\/MIC and time to Microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Clin Ther. 2013;35(6):772\u20139.","journal-title":"Clin Ther"},{"issue":"2","key":"11469_CR4","doi-asserted-by":"publisher","first-page":"e02042","DOI":"10.1128\/AAC.02042-17","volume":"62","author":"MN Neely","year":"2018","unstructured":"Neely MN, Kato L, Youn G, Kraler L, Bayard D, van Guilder M, et al. Prospective trial on the use of trough concentration versus area under the curve to determine therapeutic Vancomycin dosing. Antimicrob Agents Chemother. 2018;62(2):e02042\u201317. Published 2018 Jan 25.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"11469_CR5","doi-asserted-by":"publisher","first-page":"e00912","DOI":"10.1002\/prp2.912","volume":"10","author":"AK AbuSara","year":"2022","unstructured":"AbuSara AK, Abdelrahman DH, Habash KI, Al-Shaer MH, Le J, Nazer LH. Vancomycin therapeutic monitoring by measured trough concentration versus Bayesian-derived area under the curve in critically ill patients with cancer. Pharmacol Res Perspect. 2022;10(1):e00912.","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"11469_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1128\/AAC.01653-13","volume":"58","author":"MN Neely","year":"2014","unstructured":"Neely MN, Youn G, Jones B, Jelliffe RW, Drusano GL, Rodvold KA, et al. Are Vancomycin trough concentrations adequate for optimal dosing? Antimicrob Agents Chemother. 2014;58(1):309\u201316.","journal-title":"Antimicrob Agents Chemother"},{"key":"11469_CR7","first-page":"204993612211403","volume":"9","author":"M Chen","year":"2022","unstructured":"Chen M, Lee C, Gnyra M, Wong M. Vancomycin area under the curve\/minimum inhibitory concentration and trough level concordance-evaluation on an urban health unit. Ther Adv Infect Dis. 2022;9:20499361221140368. Published 2022 Nov 28.","journal-title":"Ther Adv Infect Dis"},{"issue":"4","key":"11469_CR8","first-page":"408","volume":"37","author":"SY Min","year":"2020","unstructured":"Min SY, Park H, Eun CJ, Huh K, Jeon K, Man Y, Lee, et al. Low correlation between Vancomycin area under the curve over 24 hours to the MIC (AUC\/MIC ratio) and the trough concentration at steady state in Methicillin-Resistant Staphylococcus aureus pneumonia. J Kor Soc Health-syst Pharm. 2020;37(4):408\u201316.","journal-title":"J Kor Soc Health-syst Pharm"},{"issue":"4","key":"11469_CR9","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/FTD.0000000000001075","volume":"45","author":"AS Lim","year":"2023","unstructured":"Lim AS, Foo SHW, Benjamin Seng JJ, Magdeline Ng TT, Chng HT, Han Z. Area-under-curve-guided versus trough-guided monitoring of vancomycin and its impact on nephrotoxicity: a systematic review and meta-analysis. Ther Drug Monit. 2023;45(4):519\u201332.","journal-title":"Ther Drug Monit"},{"issue":"9","key":"11469_CR10","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/phar.2722","volume":"42","author":"E Abdelmessih","year":"2022","unstructured":"Abdelmessih E, Patel N, Vekaria J, Crovetto B, SanFilippo S, Adams C, et al. Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: systematic review and meta-analysis. Pharmacotherapy. 2022;42(9):741\u201353.","journal-title":"Pharmacotherapy"},{"issue":"11","key":"11469_CR11","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1093\/ajhp\/zxaa036","volume":"77","author":"MJ Rybak","year":"2020","unstructured":"Rybak MJ, Le J, Lodise TP, Levine DP, Bradley JS, Liu C, et al. Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: a revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2020;77(11):835\u201364.","journal-title":"Am J Health Syst Pharm"},{"key":"11469_CR12","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/j.1875-9114.1996.tb03657.x","volume":"16","author":"JE Murphy","year":"1996","unstructured":"Murphy JE, Winder ME. Clinical pharmacokinetic pearls: bolus versus infusion equations. Pharmacotherapy. 1996;16:698\u2013700.","journal-title":"Pharmacotherapy"},{"issue":"5","key":"11469_CR13","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1093\/jac\/dkp085","volume":"63","author":"AH Thomson","year":"2009","unstructured":"Thomson AH, Staatz CE, Tobin CM, Gall M, Lovering AM. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations. J Antimicrob Chemother. 2009;63(5):1050\u20137.","journal-title":"J Antimicrob Chemother"},{"key":"11469_CR14","unstructured":"Beringer P, Winter\u2019s Basic Clinical Pharmacokinetics, Edition S. Chap. 2, Selecting the Appropriate Equation and Interpretation of Measured Drug Concentrations, p55-94. Wolters Kluwer. January 2, 2024. https:\/\/shop.lww.com\/Winter-s-Basic-Clinical-Pharmacokinetics\/p\/9781975195243."},{"issue":"5","key":"11469_CR15","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1365-2710.2006.00762.x","volume":"31","author":"P Llopis-Salvia","year":"2006","unstructured":"Llopis-Salvia P, Jim\u00e9nez-Torres NV. Population pharmacokinetic parameters of vancomycin in critically ill patients. J Clin Pharm Ther. 2006;31(5):447\u201354.","journal-title":"J Clin Pharm Ther"},{"issue":"e1","key":"11469_CR16","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1136\/ejhpharm-2020-002637","volume":"29","author":"NH Maung","year":"2022","unstructured":"Maung NH, Methaneethorn J, Wattanavijitkul T, Sriboonruang T. Comparison of area under the curve for Vancomycin from one- and two-compartment models using sparse data. Eur J Hosp Pharm. 2022;29(e1):e57\u201362.","journal-title":"Eur J Hosp Pharm"},{"issue":"4","key":"11469_CR17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1097\/FTD.0000000000000039","volume":"36","author":"J Le","year":"2014","unstructured":"Le J, Ngu B, Bradley JS, Murray W, Nguyen A, Nguyen L, et al. Vancomycin monitoring in children using bayesian estimation. Ther Drug Monit. 2014;36(4):510\u20138.","journal-title":"Ther Drug Monit"},{"issue":"6","key":"11469_CR18","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1002\/psp4.12782","volume":"11","author":"DW Uster","year":"2022","unstructured":"Uster DW, Wicha SG. Optimized sampling to estimate Vancomycin drug exposure: comparison of pharmacometric and equation-based approaches in a simulation-estimation study. CPT Pharmacometrics Syst Pharmacol. 2022;11(6):711\u201320.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"6","key":"11469_CR19","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/ajhp\/zxac366","volume":"80","author":"N Fewel","year":"2023","unstructured":"Fewel N. Accuracy of vancomycin AUC values estimated with trough-only data in a veteran population. Am J Health-Syst Pharm. 2023;80(6):390\u20134.","journal-title":"Am J Health-Syst Pharm"},{"issue":"5","key":"11469_CR20","doi-asserted-by":"publisher","first-page":"e02478","DOI":"10.1128\/AAC.02478-16","volume":"61","author":"JJ Carreno","year":"2017","unstructured":"Carreno JJ, Lomaestro B, Tietjan J, Lodise TP. Pilot study of a bayesian approach to estimate Vancomycin exposure in obese patients with limited Pharmacokinetic sampling. Antimicrob Agents Chemother. 2017;61(5):e02478\u201316. Published 2017 Apr 24.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"11469_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1097\/00007691-199402000-00005","volume":"16","author":"KA Rodvold","year":"1994","unstructured":"Rodvold KA, Rotschafer JC, Gilliland SS, Guay DR, Vance-Bryan K. Bayesian forecasting of serum Vancomycin concentrations with non-steady-state sampling strategies. Ther Drug Monit. 1994;16(1):37\u201341.","journal-title":"Ther Drug Monit"},{"issue":"5","key":"11469_CR22","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/jcpt.13474","volume":"46","author":"N Fewel","year":"2021","unstructured":"Fewel N. Vancomycin area under the curves estimated with pharmacokinetic equations using trough-only data. J Clin Pharm Ther. 2021;46(5):1426\u201332.","journal-title":"J Clin Pharm Ther"},{"issue":"7","key":"11469_CR23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/ajhp\/zxac372","volume":"80","author":"KN Arensman Hannan","year":"2023","unstructured":"Arensman Hannan KN, Rivera CG, Fewel N. Vancomycin AUC values estimated with trough-only data: accuracy in an adult academic medical center population. Am J Health-Syst Pharm. 2023;80(7):452\u20136.","journal-title":"Am J Health-Syst Pharm"},{"issue":"12","key":"11469_CR24","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1111\/bcp.14360","volume":"86","author":"R Ter Heine","year":"2020","unstructured":"Ter Heine R, Keizer RJ, van Steeg K, Smolders EJ, van Luin M, Derijks HJ, et al. Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patients. Br J Clin Pharmacol. 2020;86(12):2497\u2013506.","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"11469_CR25","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1002\/phar.2191","volume":"38","author":"RB Turner","year":"2018","unstructured":"Turner RB, Kojiro K, Shephard EA, Won R, Chang E, Chan D, et al. Review and validation of bayesian dose-optimizing software and equations for calculation of the Vancomycin area under the curve in critically ill patients. Pharmacotherapy. 2018;38(12):1174\u201383.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"11469_CR26","doi-asserted-by":"publisher","first-page":"e01026","DOI":"10.1002\/prp2.1026","volume":"10","author":"A Chen","year":"2022","unstructured":"Chen A, Gupta A, Do DH, Nazer LH. Bayesian method application: integrating mathematical modeling into clinical pharmacy through Vancomycin therapeutic monitoring. Pharmacol Res Perspect. 2022;10(6):e01026.","journal-title":"Pharmacol Res Perspect"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11469-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11469-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:30:54Z","timestamp":1758875454000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-025-11469-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11469"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11469-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"31 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the King Hussein cancer center (KHCC) Institutional Review Board (19KHCC14). Informed consent was obtained from the patient or responsible caregiver. The study have been performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1131"}}